| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448285 Disorders associated with overactivity of 5 alpha reductase; androgen dependent disorders such as seborrhoea, acne, hirsutism and/or androgenic alopecia |
| 09/10/2002 | US6448257 Tricyclic carboxamides contain a piperazine or piperidine moiety; antiinflammatory agents; heart and kidney conditions |
| 09/10/2002 | US6447748 Benzamide compounds for cancer imaging and therapy |
| 09/06/2002 | WO2002068424A1 Indole derivatives having an inhibitory effect on protein kinases |
| 09/06/2002 | WO2002068414A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 09/06/2002 | WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | WO2002068390A1 Diamides which inhibit tryptase and factor xa activity |
| 09/06/2002 | WO2002068389A2 Indole derivatives with inhibitor effects on phenol oxidase |
| 09/06/2002 | WO2002068380A1 Synthetic excitatory amino acids |
| 09/06/2002 | WO2002067939A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | WO2002067937A1 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 09/06/2002 | WO2002067930A1 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 09/06/2002 | WO2002067918A1 Novel diallylmethylamine derivative |
| 09/06/2002 | WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 09/06/2002 | WO2002050029A3 Tetracyclic derivatives as spla2 inhibitors |
| 09/06/2002 | WO2002046153A3 Process for the preparation of zafirlukast |
| 09/06/2002 | WO2002032421A8 Indole compounds as minimally physiologial function monitioring agents |
| 09/06/2002 | WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors |
| 09/06/2002 | WO2002005796A3 Use of a spla2 inhibitor for the treatment of sepsis |
| 09/06/2002 | CA2439265A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/06/2002 | CA2438828A1 Aryl carbamate derivatives, preparation and use thereof |
| 09/06/2002 | CA2437114A1 Diamides which inhibit tryptase and factor xa activity |
| 09/05/2002 | US20020123513 Administering indole-2-carboxylic amide derivatives of given formula |
| 09/05/2002 | US20020123485 For therapy of hypertension, cirrhosis and ascites |
| 09/05/2002 | DE10109280A1 Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen Indole derivatives having an inhibitory effect on protein kinases |
| 09/04/2002 | EP1236728A2 S-type 2-substituted hydroxy-2-indolinylbutyric ester compounds and process for preparation thereof |
| 09/04/2002 | EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
| 09/04/2002 | EP1236711A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 09/04/2002 | EP1235801A2 Solid pharmaceutical preparation |
| 09/04/2002 | EP1235571A1 Use of melatonin for treating androgenetic and diffuse alopecia |
| 09/04/2002 | EP1068184B1 N-aryloxyethylamine derivatives for the treatment of depression |
| 09/04/2002 | CN1367168A Indoquinone compound and its preparation method |
| 09/04/2002 | CN1090205C Condensed ring azo compound and its producing method and use |
| 09/04/2002 | CN1090204C Multifunctional cyanate ester and epoxy blends |
| 09/04/2002 | CN1090185C Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate thereof |
| 09/04/2002 | CN1090181C N-substituted 4-hydroxyindole derivatives and keratin fidre dyeing compsns. containing same |
| 09/03/2002 | US6444849 Amide derivatives |
| 09/03/2002 | US6444819 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands |
| 09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/2002 | US6444697 Synthetic compounds for treatment of inflammation |
| 09/03/2002 | CA2258960C A process for preparing naphthyridones and intermediates |
| 09/01/2002 | CA2373578A1 .beta.3, agonists and uses thereof |
| 08/29/2002 | WO2002067053A2 High speed photothermographic materials containing tellurium compounds and methods of using same |
| 08/29/2002 | WO2002066672A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/29/2002 | WO2002066462A1 Pyrazole derivatives against tgf overexpression |
| 08/29/2002 | WO2002066459A1 Indole derivatives and their use as gnrh antagonists |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066427A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2002 | WO2002066426A2 Fluoro oxindole derivatives as modulators of kcnq potassium channels |
| 08/29/2002 | WO2002066073A1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression |
| 08/29/2002 | WO2002042304A3 Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120583 Dynamic number authentication for credit/debit cards |
| 08/29/2002 | US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 08/29/2002 | US20020120137 FXR modulators |
| 08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |
| 08/29/2002 | US20020119976 Tetracyclic derivatives, process of preparation and use |
| 08/29/2002 | US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| 08/29/2002 | US20020119971 Antiinflammatory agents; skin disorders; central nervous system disorders |
| 08/29/2002 | US20020119966 Central nervous system disorders |
| 08/29/2002 | US20020119961 Bridged piperazine derivatives |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | US20020119910 Drug delivery |
| 08/29/2002 | US20020119191 Pharmaceutical or food composition for treatment or prevention of brain edema |
| 08/29/2002 | CA2438805A1 Fluoro oxindole derivatives as modulators of kcnq potassium channels |
| 08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 08/28/2002 | EP1233768A1 Carvedilol methanesulfonate |
| 08/28/2002 | EP1140898B1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 08/28/2002 | EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease |
| 08/28/2002 | CN1365972A Indole derivatives and its anticancer usage |
| 08/28/2002 | CN1365971A Antibacterial activity, induction, separation and synthesis of N-acyltryptamine derivative as plant protecting chemical |
| 08/28/2002 | CN1089765C 1H-pyrido [3,4-b] indole-4-carboxamide derivatives, preparation and application thereof in therapeutics |
| 08/28/2002 | CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 08/27/2002 | US6441192 Adding acid chloride and alkyl or aryl magnesium halide separately and simultaneously to a stirred solution of an indole such that the two reagents do not come into immediate contact; synchronised rates of molar addition |
| 08/27/2002 | US6441175 Useful in treating various neuropsychological disorders including, schizophrenia, dementia, depression, anxiety, parkinson-like motor disorders and motion disorders |
| 08/27/2002 | US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection |
| 08/27/2002 | US6441021 Type-iv collagenase inhibitors |
| 08/27/2002 | US6441004 Monocyte chemoattractant protein-1 inhibitor compounds |
| 08/27/2002 | US6440889 Amine elimination process for making single-site catalysts |
| 08/27/2002 | CA2167039C Alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them |
| 08/27/2002 | CA2045955C Indole derivatives |
| 08/22/2002 | WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/22/2002 | WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064564A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor |
| 08/22/2002 | WO2002064551A1 Hiv protease inhibitors based on amino acid derivatives |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002064533A1 Obtaining anthracene and carbazole by melt-crystallization |
| 08/22/2002 | WO2002064133A1 Preparations for controlling concentration in blood |
| 08/22/2002 | WO2002040008A3 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 08/22/2002 | WO2002038557A3 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
| 08/22/2002 | WO2002004412A3 Tyrosine derivatives as phosphatase inhibitors |
| 08/22/2002 | US20020115869 Lambda-shaped carbazole and main-chain NLO polyurethane containing the same |
| 08/22/2002 | US20020115857 Useful as an intermediate of a carbocyclic nucleoside anti-viral agent; reacting 2-azabicyclo(2.2.1)hept-5-en-3-one with a sulfonyl halide or phosphoryl halide and then with a nucleic acid base |
| 08/22/2002 | US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects |